Skip to content
★ Sign in to follow
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
18
Company
1
▲ Purchases (3 ops.)
€391k
▼ Sales (8 ops.)
€3.2M

Latest filing published 14 Sept 2026 for TransMedics Group, Inc., €94k.

Filing timeline

BuySale
David Weill

Insider track record

Disclosed buys
3
Disclosed sells
8
T+90 hit rate
100%
T+90 mean return
+8.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

David Weill: trading record in brief

This profile gathers the share dealings of David Weill in TransMedics Group, Inc. In total, 18 filings cover trades dated from 11 November 2019 to 11 September 2026.

On the open market, the record shows 3 purchases worth €391k and 8 sales worth €3.2M. Sales outweigh purchases by €2.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 4 option exercises. Since January 2026: 1 purchase and 1 sale on the market.

A typical purchase (the median) is worth €143k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 14 September 2026, the filings show an open-market purchase worth €94k in TransMedics Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Weill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations